FDA panel recommends Pfizer vaccine for children ages 5 to 11

The FDA panel concluded that the benefits of Pfizer's COVID-19 vaccine for young children outweigh the risks.

from Livescience.com https://ift.tt/3npWIqA
via IFTTT